2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Report: not found

      BRCA1 recruitment to damaged DNA sites is dependent on CDK9

      report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Double strand break lesions, the most toxic type of DNA damage, are repaired primarily through 2 distinct pathways: homology-directed recombination (HR) and non-homologous end-joining (NHEJ). BRCA1 and 53BP1, 2 proteins containing the BRCT modular domain, play an important role in DNA damage response (DDR) by orchestrating the decision between HR and NHEJ, but the precise mechanisms regarding both pathways are not entirely understood. Previously, our group identified a putative interaction between BRCA1 and BARD1 (BRCA1-associated RING domain 1) and the cyclin-dependent kinase (CDK9). CDK9 is a component of the positive transcription elongation complex and has been implicated in genome integrity maintenance associated with the replication stress response. Here we show that CDK9 interacts with endogenous BRCA1 and BARD1 mediated by their RING finger and BRCT domains, and describe CDK9 ionizing radiation-induced foci (IRIF) formation and its co-localization with BRCA1 in DNA damage sites. Cells lacking CDK9 are characterized by an altered γ−H2AX foci dynamics after DNA damage, a reduced efficiency in HR but not in NHEJ repair, failure to form BRCA1 and RAD51 IRIF and increased sensitivity to genotoxic agents. These data indicate that CDK9 is a player in the DDR and is consistent with its participation in HR pathway by modulating BRCA1 response.

          Related collections

          Author and article information

          Journal
          Cell Cycle
          Cell Cycle
          KCCY
          kccy20
          Cell Cycle
          Taylor & Francis
          1538-4101
          1551-4005
          2017
          22 February 2017
          : 16
          : 7
          : 665-672
          Affiliations
          [a ] Programa de Pesquisa Clínica, Instituto Nacional de Câncer , Rio de Janeiro, Brazil
          [b ] Instituto Federal do Rio de Janeiro - IFRJ , Rio de Janeiro, Brazil
          [c ] Faculdade de Farmácia – Universidade Federal do Rio de Janeiro , Rio de Janeiro, RJ, Brazil
          [d ] Cancer Epidemiology Program, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL, USA
          Author notes
          CONTACT Marcelo A. Carvalho marcelo.carvalho@ 123456ifrj.edu.br Instituto Federal do Rio de Janeiro, Campus Rio de Janeiro, Laboratório de Genética Molecular , Rua Senador Furtado, 121, Rio de Janeiro, RJ, Brazil, 20270–021

          Color versions of one or more of the figures in this article can be found online at www.tandfonline.com/kccy.

          Supplemental data for this article can be accessed on the publisher's website.

          Author information
          http://orcid.org/0000-0002-1171-1030
          http://orcid.org/0000-0003-4130-8215
          http://orcid.org/0000-0001-7669-3980
          http://orcid.org/0000-0001-8088-6195
          http://orcid.org/0000-0002-1115-8319
          http://orcid.org/0000-0002-8448-4801
          http://orcid.org/0000-0002-7053-0053
          Article
          PMC5397266 PMC5397266 5397266 1295177
          10.1080/15384101.2017.1295177
          5397266
          28278048
          e363818e-d6c2-4fed-a02c-e64b7a6ffdef
          © 2017 Taylor & Francis
          History
          : 15 June 2016
          : 27 January 2017
          : 8 February 2017
          Page count
          Figures: 5, Tables: 0, Equations: 0, References: 51, Pages: 8
          Categories
          Report

          homologous recombination,BRCA1,CDK9,DNA damage repair
          homologous recombination, BRCA1, CDK9, DNA damage repair

          Comments

          Comment on this article